We analysed data from 80 patients who tested positive for SARS‐CoV‐2 RNA who had previously been HLA typed to support transplantation. Data were combined from two adjacent centres in Manchester and Leeds to achieve a sufficient number for early analysis. HLA frequencies observed were compared against two control populations: first, against published frequencies in a UK deceased donor population (n = 10,000) representing the target population of the virus, and second, using a cohort of individuals from the combined transplant waiting lists of both centres (n = 308), representing a comparator group of unaffected individuals of the same demographic. We report a significant HLA association with HLA‐ DQB1*06 (53% vs. 36%; p < .012; OR 1.96; 9...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between i...
Background: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been ...
Development of adaptive immunity after COVID-19 and after vaccination against SARS-CoV-2 is predicat...
SARS-CoV-2 infection results in different outcomes ranging from asymptomatic infection to mild or se...
BACKGROUND: SARS-CoV-2 infection is heterogeneous in clinical presentation and disease evolution. To...
Key Messages: 1. Human leukocyte antigen (HLA) genotypes from 102 SARS patients (susceptible) and ...
SARS-CoV-2 infection results in different outcomes ranging from asymptomatic infection to mild or se...
The class I and class II Human Leucocyte Antigens (HLA) are an integral part of the host adaptive im...
SARS-CoV-2 appears to induce diverse innate and adaptive immune responses, resulting in different cl...
BackgroundSince the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been in...
Background: Human leukocyte antigen (HLA) plays an important role in immune responses to infections...
Understanding how human leukocyte antigen (HLA) polymorphism affects both the susceptibility and sev...
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS...
The COVID-19 pandemic has markedly impacted on cultural, political, and economic structures all over...
The extraordinary variation of the human leukocyte antigen (HLA) molecules is critical for diversify...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between i...
Background: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been ...
Development of adaptive immunity after COVID-19 and after vaccination against SARS-CoV-2 is predicat...
SARS-CoV-2 infection results in different outcomes ranging from asymptomatic infection to mild or se...
BACKGROUND: SARS-CoV-2 infection is heterogeneous in clinical presentation and disease evolution. To...
Key Messages: 1. Human leukocyte antigen (HLA) genotypes from 102 SARS patients (susceptible) and ...
SARS-CoV-2 infection results in different outcomes ranging from asymptomatic infection to mild or se...
The class I and class II Human Leucocyte Antigens (HLA) are an integral part of the host adaptive im...
SARS-CoV-2 appears to induce diverse innate and adaptive immune responses, resulting in different cl...
BackgroundSince the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been in...
Background: Human leukocyte antigen (HLA) plays an important role in immune responses to infections...
Understanding how human leukocyte antigen (HLA) polymorphism affects both the susceptibility and sev...
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS...
The COVID-19 pandemic has markedly impacted on cultural, political, and economic structures all over...
The extraordinary variation of the human leukocyte antigen (HLA) molecules is critical for diversify...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine immunogenicity varies between i...
Background: Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, there has been ...
Development of adaptive immunity after COVID-19 and after vaccination against SARS-CoV-2 is predicat...